FI923393A - Heteroarylsubstituerade hydroxylaminderivat - Google Patents
Heteroarylsubstituerade hydroxylaminderivat Download PDFInfo
- Publication number
- FI923393A FI923393A FI923393A FI923393A FI923393A FI 923393 A FI923393 A FI 923393A FI 923393 A FI923393 A FI 923393A FI 923393 A FI923393 A FI 923393A FI 923393 A FI923393 A FI 923393A
- Authority
- FI
- Finland
- Prior art keywords
- aryl
- lower alkyl
- cycloalkyl
- carbocyclic
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73807591A | 1991-07-30 | 1991-07-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI923393A0 FI923393A0 (fi) | 1992-07-27 |
FI923393A true FI923393A (fi) | 1993-01-31 |
Family
ID=24966464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI923393A FI923393A (fi) | 1991-07-30 | 1992-07-27 | Heteroarylsubstituerade hydroxylaminderivat |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0526402B1 (fi) |
JP (1) | JPH0641104A (fi) |
KR (1) | KR930002329A (fi) |
AT (1) | ATE162525T1 (fi) |
AU (1) | AU662339B2 (fi) |
CA (1) | CA2074797A1 (fi) |
CZ (1) | CZ235192A3 (fi) |
DE (1) | DE69224115T2 (fi) |
DK (1) | DK0526402T3 (fi) |
ES (1) | ES2111059T3 (fi) |
FI (1) | FI923393A (fi) |
GR (1) | GR3026254T3 (fi) |
HU (1) | HUT66626A (fi) |
IE (1) | IE922471A1 (fi) |
IL (1) | IL102612A (fi) |
MX (1) | MX9204418A (fi) |
NO (1) | NO178925C (fi) |
NZ (1) | NZ243752A (fi) |
PH (1) | PH30092A (fi) |
TW (1) | TW281672B (fi) |
ZA (1) | ZA925688B (fi) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6268392B1 (en) | 1994-09-13 | 2001-07-31 | G. D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
US6262277B1 (en) | 1994-09-13 | 2001-07-17 | G.D. Searle And Company | Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
US6642268B2 (en) | 1994-09-13 | 2003-11-04 | G.D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors |
US5516789A (en) * | 1995-04-12 | 1996-05-14 | Abbott Laboratories | Lipoxygenase and cyclooxygenase inhibiting compounds |
BE1010487A6 (nl) | 1996-06-11 | 1998-10-06 | Unilin Beheer Bv | Vloerbekleding bestaande uit harde vloerpanelen en werkwijze voor het vervaardigen van dergelijke vloerpanelen. |
BR9916565A (pt) | 1998-12-23 | 2002-01-29 | Searle Llc | Combinações de inibidores do transporte ácido da bile ileal e derivados do ácido fìbrico para indicações cardiovasculares |
US6569905B1 (en) | 1998-12-23 | 2003-05-27 | G.D. Searle, Llc | Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications |
PT1140184E (pt) | 1998-12-23 | 2003-10-31 | Searle Llc | Combinacoes de inibidores de proteina de transferencia de ester de colesterilo com derivados de acido nicotinico para indicacoes cardiovasculares |
CA2356422C (en) | 1998-12-23 | 2008-09-16 | G.D. Searle Llc | Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications |
ATE242009T1 (de) | 1998-12-23 | 2003-06-15 | Searle Llc | Kombinationen von cholesteryl ester transfer protein inhibitoren und fibronsäure derivaten für kardiovaskuläre indikationen |
AU2157400A (en) | 1998-12-23 | 2000-07-31 | G.D. Searle & Co. | Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications |
IL143943A0 (en) | 1998-12-23 | 2002-04-21 | Searle Llc | Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications |
EP1286984A2 (en) | 2000-03-10 | 2003-03-05 | Pharmacia Corporation | Method for the preparation of tetrahydrobenzothiepines |
DE10103506A1 (de) * | 2001-01-26 | 2002-08-14 | Ingo S Neu | Pharmazeutische Zusammensetzung zur Behandlung von Multiple Sklerose |
CA2464685A1 (en) | 2001-11-02 | 2003-05-15 | G.D. Searle Llc | Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake |
MXPA04006255A (es) | 2002-01-17 | 2004-09-27 | Pharmacia Corp | Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato. |
DE10229762A1 (de) * | 2002-07-03 | 2004-01-22 | Aventis Pharma Deutschland Gmbh | Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase |
ES2361924T3 (es) | 2002-12-20 | 2011-06-24 | X-Ceptor Therapeutics, Inc. | Derivados de isoquinolinona y su uso como agentes terapéuticos. |
EP3509588B1 (en) | 2016-09-12 | 2023-06-07 | Integral Health,Inc. | Bicyclic compounds useful as gpr120 modulators |
US10800773B2 (en) | 2016-09-12 | 2020-10-13 | Integral Health, Inc. | Monocyclic compounds useful as GPR120 modulators |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0196184B1 (en) * | 1985-03-16 | 1992-09-16 | The Wellcome Foundation Limited | Aryl derivatives |
US4761403A (en) * | 1986-04-09 | 1988-08-02 | Abbott Laboratories | Lipoxygenase inhibiting compounds |
DE3882732T2 (de) * | 1987-02-10 | 1993-12-02 | Abbott Lab | Indol, Benzofuran, Benzothiophen enthaltende, Lipoxygenase hemmende Verbindungen. |
US4981865A (en) * | 1989-05-26 | 1991-01-01 | Warner-Lambert Co. | N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents |
-
1992
- 1992-07-21 ES ES92810559T patent/ES2111059T3/es not_active Expired - Lifetime
- 1992-07-21 DK DK92810559T patent/DK0526402T3/da active
- 1992-07-21 AT AT92810559T patent/ATE162525T1/de not_active IP Right Cessation
- 1992-07-21 EP EP92810559A patent/EP0526402B1/en not_active Expired - Lifetime
- 1992-07-21 DE DE69224115T patent/DE69224115T2/de not_active Expired - Fee Related
- 1992-07-22 AU AU20482/92A patent/AU662339B2/en not_active Ceased
- 1992-07-23 IL IL10261292A patent/IL102612A/en not_active IP Right Cessation
- 1992-07-24 TW TW081105850A patent/TW281672B/zh active
- 1992-07-24 PH PH44703A patent/PH30092A/en unknown
- 1992-07-27 FI FI923393A patent/FI923393A/fi not_active Application Discontinuation
- 1992-07-27 CZ CS922351A patent/CZ235192A3/cs unknown
- 1992-07-28 CA CA002074797A patent/CA2074797A1/en not_active Abandoned
- 1992-07-28 JP JP4201496A patent/JPH0641104A/ja active Pending
- 1992-07-28 NZ NZ243752A patent/NZ243752A/en unknown
- 1992-07-29 HU HU9202479A patent/HUT66626A/hu unknown
- 1992-07-29 NO NO922987A patent/NO178925C/no unknown
- 1992-07-29 IE IE247192A patent/IE922471A1/en not_active Application Discontinuation
- 1992-07-29 ZA ZA925688A patent/ZA925688B/xx unknown
- 1992-07-29 MX MX9204418A patent/MX9204418A/es unknown
- 1992-07-29 KR KR1019920013541A patent/KR930002329A/ko active IP Right Grant
-
1998
- 1998-02-27 GR GR980400432T patent/GR3026254T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0526402A1 (en) | 1993-02-03 |
KR930002329A (ko) | 1993-02-23 |
TW281672B (fi) | 1996-07-21 |
CA2074797A1 (en) | 1993-01-31 |
NO178925C (no) | 1996-07-03 |
GR3026254T3 (en) | 1998-05-29 |
PH30092A (en) | 1996-12-27 |
ES2111059T3 (es) | 1998-03-01 |
NZ243752A (en) | 1994-09-27 |
MX9204418A (es) | 1993-02-01 |
EP0526402B1 (en) | 1998-01-21 |
NO922987D0 (no) | 1992-07-29 |
IE922471A1 (en) | 1993-02-10 |
FI923393A0 (fi) | 1992-07-27 |
CZ235192A3 (en) | 1993-10-13 |
ATE162525T1 (de) | 1998-02-15 |
NO922987L (no) | 1993-02-01 |
JPH0641104A (ja) | 1994-02-15 |
HUT66626A (en) | 1994-12-28 |
AU662339B2 (en) | 1995-08-31 |
DE69224115T2 (de) | 1998-08-20 |
IL102612A (en) | 1996-11-14 |
IL102612A0 (en) | 1993-01-14 |
DK0526402T3 (da) | 1998-09-14 |
NO178925B (no) | 1996-03-25 |
ZA925688B (en) | 1993-03-31 |
AU2048292A (en) | 1993-02-04 |
DE69224115D1 (de) | 1998-02-26 |
HU9202479D0 (en) | 1992-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI923393A (fi) | Heteroarylsubstituerade hydroxylaminderivat | |
ATE368655T1 (de) | Stickstoffhaltige heterocyclische verbindung und arzneimittel davon | |
DK1022272T3 (da) | Substituerede, fusionerede, heterocykliske forbindelser | |
DK1424330T3 (da) | Aktivator for peroxisom proliferator-responsiv receptor delta | |
ATE542805T1 (de) | Ppar-delta aktivatoren | |
FI921327A (fi) | Nya azadekalinamider och tioamider som inhibitorer av kolesterolbiosyntes | |
DE60223904D1 (de) | Benzylaminanalogen | |
DE69734952D1 (de) | Anilide als ACAT-Hemmer | |
BR9200057A (pt) | Composto e composicao farmaceutica | |
DE60100207D1 (de) | Verfahren zu Synthese von N-(mercaptoacyl)-aminosäure Derivaten von alfasubstituierte Acrylsäuren an | |
DE69911946D1 (de) | Phosphonsäure-diester-derivate | |
NZ337142A (en) | Hydroxamic acid compounds | |
EP1069115A4 (en) | METHOD FOR PRODUCING OXAZOLIDIN-2-ONE COMPOUNDS | |
BR8003950A (pt) | Composicoes herbicidas, baseadas em derivados de m-anilido-uretana | |
DK1078916T3 (da) | Fremgangsmåde til fremstilling af N-acylaminosyreestere og N-acylaminoacetaler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or assigment of application |
Owner name: NOVARTIS AG |
|
FD | Application lapsed |